Latest News

2024 Key Insights: Psoriasis
2024 Key Insights: Psoriasis

December 13th 2024

Join Dermatology Times’ quarterly editor in chief Christopher Bunick, MD, PhD, discussed transformative advances in psoriasis care.

SB5 is Effective and Safe for Long-Term Psoriasis Treatment
SB5 is Effective and Safe for Long-Term Psoriasis Treatment

December 12th 2024

Deucravacitinib Improves Psoriasis Symptoms in Japanese Patients
Deucravacitinib Improves Psoriasis Symptoms in Japanese Patients

December 11th 2024

Psoriasis Patients Without Insurance Are More Likely Unable to Obtain Care
Psoriasis Patients Without Insurance Are More Likely Unable to Obtain Care

December 10th 2024

Patient-Reported Outcomes and Treatment Switching in Plaque Psoriasis
Patient-Reported Outcomes and Treatment Switching in Plaque Psoriasis

December 6th 2024

© 2024 MJH Life Sciences

All rights reserved.